Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ACTIVE_NOT_RECRUITING
Status
Conditions
- B-Cell Lymphoma, Unspecified
- Grade 1 Follicular Lymphoma
- Grade 2 Follicular Lymphoma
- Grade 3a Follicular Lymphoma
- Recurrent Burkitt Lymphoma
- Recurrent Diffuse Large B-Cell Lymphoma
- Recurrent Follicular Lymphoma
- Recurrent Marginal Zone Lymphoma
- Refractory Burkitt Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Refractory Follicular Lymphoma
- Transformed Recurrent Non-Hodgkin Lymphoma
- B-Cell
Interventions
- DRUG: Lenalidomide
- BIOLOGICAL: Obinutuzumab
- DRUG: Venetoclax
Sponsor
Beth Christian
Collaborators
- [object Object]
- [object Object]